Evaluation of CD4+/CD8 + T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and v antigens of Yersinia pestis

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 64-73

  Gupta, Geetanjali ^a   Ali, Riyasat ^a   Khan, Arif Azam ^a   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Elispot; F1 V antigens; FACS; IFN ; Y. pestis

Indexed keywords

EPITOPE; GAMMA INTERFERON; INTERLEUKIN 4; PERFORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOMODULATION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; YERSINIA PESTIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; INTERFERON-GAMMA; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; PEPTIDES; PERFORIN; PLAGUE; PORE FORMING CYTOTOXIC PROTEINS; VACCINATION; YERSINIA PESTIS;

EID: 84856085151     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.10.012     Document Type: Article

References (56)

1. R.D. Perry, and J.D. Fetherston Yersinia pestis-etiologic agent of plague Clin Microbiol Rev 10 1997 35 66
2. M. Drancourt, and D. Raoult Molecular insights into the history of plague Microbes Infect/Inst Pasteur 4 2002 105 109 (Pubitemid 34127997)
3. H.J. Koornhof, R.A. Smego Jr. , and M. Nicol Yersiniosis. II: The pathogenesis of Yersinia infections Eur J Clin Microbiol Infect Dis 18 1999 87 112
4. V. Mett, J. Lyons, K. Musiychuk, J.A. Chichester, T. Brasil, and R. Couch A plant-produced plague vaccine candidate confers protection to monkeys Vaccine 25 2007 3014 3017 (Pubitemid 46482733)
5. B.S. Powell, G.P. Andrews, J.T. Enama, S. Jendrek, C. Bolt, and P. Worsham Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague Biotechnol Prog 21 2005 1490 1510 (Pubitemid 41443005)
6. E.D. Williamson Plague vaccine research and development J Appl Microbiol 91 2001 606 608 (Pubitemid 32948382)
7. E.D. Williamson, H.C. Flick-Smith, E. Waters, J. Miller, I. Hodgson, and C.S. Le Butt Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates Microb Pathog 42 2007 11 21 (Pubitemid 44932133)
8. S.M. Jones, K.F. Griffin, I. Hodgson, and E.D. Williamson Protective efficacy of a fully recombinant plague vaccine in the guinea pig Vaccine 21 2003 3912 3918 (Pubitemid 37338218)
9. E.D. Williamson, H.C. Flick-Smith, C. Lebutt, C.A. Rowland, S.M. Jones, and E.L. Waters Human immune response to a plague vaccine comprising recombinant F1 and V antigens Infect Immun 73 2005 3598 3608 (Pubitemid 40745904)
10. Y. Du, R. Rosqvist, and A. Forsberg Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis Infect Immun 70 2002 1453 1460 (Pubitemid 34163423)
11. G.W. Anderson Jr. , P.L. Worsham, C.R. Bolt, G.P. Andrews, S.L. Welkos, and A.M. Friedlander Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis Am J Trop Med Hyg 56 1997 471 473 (Pubitemid 27188439)
12. G.P. Andrews, D.G. Heath, G.W. Anderson Jr. , S.L. Welkos, and A.M. Friedlander Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge Infect Immun 64 1996 2180 2187 (Pubitemid 26167232)
13. J. Hill, C. Copse, S. Leary, A.J. Stagg, E.D. Williamson, and R.W. Titball Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis Infect Immun 71 2003 2234 2238 (Pubitemid 36368759)
14. L.J. Mota Type III secretion gets an LcrV tip Trends Microbiol 14 2006 197 200
15. J. Pettersson, A. Holmstrom, J. Hill, S. Leary, E. Frithz-Lindsten, and A. von Euler-Matell The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation Mol Microbiol 32 1999 961 976 (Pubitemid 29255763)
16. R. Nakajima, and R.R. Brubaker Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha Infect Immun 61 1993 23 31 (Pubitemid 23015395)
17. R. Nakajima, V.L. Motin, and R.R. Brubaker Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization Infect Immun 63 1995 3021 3029
18. A. Sing, D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, and C.J. Kirschning Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression J Exp Med 196 2002 1017 1024 (Pubitemid 35231760)
19. S. Welkos, A. Friedlander, D. McDowell, J. Weeks, and S. Tobery V antigen of Yersinia pestis inhibits neutrophil chemotaxis Microb Pathog 24 1998 185 196 (Pubitemid 28138576)
20. A.V. Philipovskiy, C. Cowan, C.R. Wulff-Strobel, S.H. Burnett, E.J. Kerschen, and D.A. Cohen Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis Infect Immun 73 2005 1532 1542 (Pubitemid 40470739)
21. A. Palin, A. Chattopadhyay, S. Park, G. Delmas, R. Suresh, and S. Senina An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge Vaccine 25 2007 741 750 (Pubitemid 44856103)
22. S.C. Straley, and P.A. Harmon Yersinia pestis grows within phagolysosomes in mouse peritoneal macrophages Infect Immun 45 1984 655 659 (Pubitemid 14066180)
23. M.A. Parent, K.N. Berggren, L.W. Kummer, L.B. Wilhelm, F.M. Szaba, and I.K. Mullarky Cell-mediated protection against pulmonary Yersinia pestis infection Infect Immun 73 2005 7304 7310 (Pubitemid 41587630)
24. Jr-Shiuan Lin, Lawrence W. Kummer, Frank M. Szaba, and Stephen T. Smiley IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection J Immunol 186 2011 1675 1684
25. S.H. Kaufmann Immunity to intracellular bacteria Annu Rev Immunol 11 1993 129 163 (Pubitemid 23115004)
26. M.J. Bevan Helping the CD8(+) T-cell response Nat Rev Immunol 4 2004 595 602
27. M. Catalfamo, and P.A. Henkart Perforin and the granule exocytosis cytotoxicity pathway Curr Opin Immunol 15 2003 522 527 (Pubitemid 37130192)
28. V. Appay, J.J. Zaunders, L. Papagno, J. Sutton, A. Jaramillo, and A. Waters Characterization of CD4+(+) CTLs ex vivo J Immunol 168 2002 5954 5958
29. H. Echchakir, M. Bagot, G. Dorothee, D. Martinvalet, S. Le Gouvello, and L. Boumsell Cutaneous T cell lymphoma reactive CD4++ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis J Invest Dermatol 115 2000 74 80 (Pubitemid 30470195)
30. P.J. Norris, M. Sumaroka, C. Brander, H.F. Moffett, S.L. Boswell, and T. Nguyen Multiple effector functions mediated by human immunodeficiency virus-specific CD4+(+) T-cell clones J Virol 75 2001 9771 9779 (Pubitemid 32900112)
31. H. Ohminami, M. Yasukawa, and S. Fujita HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide Blood 95 2000 286 293 (Pubitemid 30017254)
32. K.L. DeBord, D.M. Anderson, M.M. Marketon, K.A. Overheim, R.W. DePaolo, and N.A. Ciletti Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV Infect Immun 74 2006 4910 4914 (Pubitemid 44157279)
33. A. Sing, D. Rost, N. Tvardovskaia, A. Roggenkamp, A.M. Geiger, and C.J. Kirschning Mechanisms of Yersinia enterocolitica evasion of the host innate immune response by V antigen Adv Exp Med Biol 529 2003 165 167 (Pubitemid 36702798)
34. E.D. Williamson, R.J. Beedham, A.M. Bennett, S.D. Perkins, J. Miller, and L.W. Baillie Presentation of protective antigen to the mouse immune system: immune sequelae J Appl Microbiol 87 1999 315 317 (Pubitemid 29430348)
35. J.B. Uppada, A.A. Khan, A.A. Bhat, R. Deshmukh, and D.N. Rao Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of V antigen of Yersinia pestis by intranasal immunization in microparticles Med Microbiol Immunol 198 2009 247 256
36. L. Sabhnani, M. Manocha, K. Sridevi, D. Shashikiran, R. Rayanade, and D.N. Rao Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles FEMS Immunol Med Microbiol 38 2003 215 229 (Pubitemid 37289746)
37. V. Tripathi, K.T. Chitralekha, A.R. Bakshi, D. Tomar, R.A. Deshmukh, and M.A. Baig Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery Vaccine 24 2006 3279 3289
38. A.A. Khan, J.P. Babu, G. Gupta, and D.N. Rao Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Yersinia pestis Vaccine 26 2008 316 332
39. G. Gupta, A.A. Khan, and D.N. Rao Cell-mediated immune response and Th1/Th2 cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis Scand J Immunol 71 2010 186 198
40. R.M. Zinkernagel On natural and artificial vaccinations Annu Rev Immunol 21 2003 515 546 (Pubitemid 37174540)
41. Jim Hill, Sophie E.C. Leary, Kate F. Griffin, E. Daine Williamson, and Richard W. Titball Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization Infect Immun 11 1997 4476 4482 (Pubitemid 27463214)
42. X. Ma TNF-alpha and IL-12: a balancing act in macrophage functioning Microbes Infect 3 2001 121 129 (Pubitemid 32209329)
43. K. Schroder, P.J. Hertzog, T. Ravasi, and D.A. Hume Interferon-gamma: an overview of signals, mechanisms and functions J Leukoc Biol 75 2004 163 189 (Pubitemid 38174573)
44. R.A. Lukaszewski, D.J. Kenny, R. Taylor, D.G. Rees, M.G. Hartley, and P.C. Oyston Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils Infect Immun 73 2005 7142 7150 (Pubitemid 41587611)
45. B. Li, and R. Yang Interaction between Yersinia pestis and the host immune system Infect Immun 76 2008 1804 1811 (Pubitemid 351656114)
46. S.J. Elvin, and E.D. Williamson Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague Microb Pathog 37 2004 177 184 (Pubitemid 39349041)
47. Y. Do, C.G. Park, Y.S. Kang, S.H. Park, R.M. Lynch, and H. Lee Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells Eur J Immunol 38 2008 20 29
48. S.M. Kaech, E.J. Wherry, and R. Ahmed Effector and memory T-cell differentiation: implications for vaccine development Nat Rev Immunol 2 2002 251 262 (Pubitemid 37323225)
49. R.R. Brubaker Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen) Infect Immun 71 2003 3673 3681 (Pubitemid 36753686)
50. M.A. Parent, L.B. Wilhelm, L.W. Kummer, F.M. Szaba, I.K. Mullarky, and S.T. Smiley Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection Infect Immun 74 2006 3381 3386 (Pubitemid 43794528)
51. L.M. Faber, S.A. van Luxemburg-Heijs, W.F. Veenhof, R. Willemze, and J.H. Falkenburg Generation of CD4 + cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity Blood 86 1995 2821 2828
52. A.M. Krensky, C.S. Reiss, J.W. Mier, J.L. Strominger, and S.J. Burakoff Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4 + Proc Natl Acad Sci U S A 79 1982 2365 2369 (Pubitemid 12161322)
53. C. Paludan, K. Bickham, S. Nikiforow, M.L. Tsang, K. Goodman, and W.A. Hanekom Epstein-Barr nuclear antigen 1-specific CD4+(+) Th1 cells kill Burkitt's lymphoma cells J Immunol 169 2002 1593 1603 (Pubitemid 34809208)
54. C.F. Zheng, L.L. Ma, G.J. Jones, M.J. Gill, A.M. Krensky, and P. Kubes Cytotoxic CD4 + T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients Blood 109 2007 2049 2057 (Pubitemid 46348205)
55. C. Jolly, and Q.J. Sattentau Regulated secretion from CD4++ T cells Trends Immunol 28 2007 474 481
56. W.T. Liu, H.L. Hsu, C.C. Liang, C.C. Chuang, H.C. Lin, and Y.T. Liu A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen FEMS Immunol Med Microbiol 51 2007 58 69